SCHEMBL14478760

COCC1O[C@@H](O[C@H]2C(C)C(C)[C@@H](O[C@H]3C(C)C(OC)[C@H](OC)O[C@H]3COC)O[C@H]2COC)C(OC)[C@@H](C)[C@@H]1O[C@@H]1OC(COS(=O)(=O)O)[C@@H](O[C@@H]2O[C@@H](COS(=O)(=O)O)[C@@H](O[C@H]3O[C@@H](COS(=O)(=O)O)[C@@H](OOO)C(OOO)C3OOO)C(OOO)C2OS(=O)(=O)O)[C@H](C)C1C

nearest known ligand 0.47

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	SERPINC1	P01008	3/20	0.47

▸	FGF1	P05230	4/20	0.46

▸	HPSE	Q9Y251	8/20	0.43

▸	FGF2	P09038	1/20	0.42

▸	F10	P00742	5/20	0.39

▸	F2	P00734	1/20	0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL15702852	0.90	SERPINC1 (0.42)	SERPINC1FGF1HPSEFGF2F10
SCHEMBL25990456	0.87	SERPINC1 (0.55)	SERPINC1FGF1HPSEFGF2F10
SCHEMBL14478759	0.85	SERPINC1 (0.41)	SERPINC1FGF1HPSEFGF2F10
SCHEMBL14039089	0.85	SERPINC1 (0.38)	SERPINC1FGF1HPSEFGF2F10
SCHEMBL12551994	0.85	SERPINC1 (0.38)	SERPINC1FGF1HPSEFGF2F10
SCHEMBL18539806	0.83	FGF1 (0.50)	SERPINC1FGF1HPSEFGF2F10
SCHEMBL18826197	0.83	FGF1 (0.54)	SERPINC1FGF1HPSEFGF2F10
SCHEMBL14039147	0.79	SERPINC1 (0.34)	SERPINC1FGF1FGF2F10
SCHEMBL12551998	0.79	SERPINC1 (0.34)	SERPINC1FGF1FGF2F10
SCHEMBL12552015	0.79	SERPINC1 (0.40)	SERPINC1FGF1HPSEFGF2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-8703738-B2	Biotinylated hexadecasaccharides, preparation and use thereof	SANOFI (FR)	2014-04-22	—	—	US	disclosed
US-20130004551-A1	BIOTINYLATED HEXADECASACCHARIDES, PREPARATION AND USE THEREOF	SANOFI (FR)	2013-01-03	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20130004551-A1	BIOTINYLATED HEXADECASACCHARIDES, PREPARATION AND USE THEREOF	BTD, OSTC, FUT6	SERPINC1 291/4885FGF1 2874/4885HPSE 427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.